Skip to main content
logo
Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · Real-Time Price · USD
1.570
-0.080 (-4.85%)
At close: Jul 27, 2026, 4:00 PM EDT
1.560
-0.010 (-0.64%)
After-hours: Jul 27, 2026, 5:19 PM EDT

Biodexa Pharmaceuticals Income Statement

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
--0.380.70.58
Revenue Growth
---45.49%20.93%68.51%
Gross Profit
--0.380.70.58
Selling, General & Admin
4.843.794.344.542.95
Research & Development
3.965.444.075.114.65
Other Operating Expenses
-0.15-0.03-0.01-0.02-0.02
Total Operating Expenses
8.659.28.49.637.58
Operating Income
-8.65-9.2-8.01-8.93-7
Interest Income
2.393.390.570.50.94
Interest Expense
-0.23-0.17-0.04-0.05-0.04
Total Non-Operating Income (Expense)
2.163.220.530.440.89
Pretax Income
-6.49-5.98-7.49-8.49-6.11
Provision for Income Taxes
-0.11-0.25-0.41-0.83-0.65
Net Income
-6.38-5.73-7.08-7.66-5.46
Net Income to Common
-6.38-5.73-7.08-7.66-5.46
Net Income Growth
-----
Shares Outstanding (Basic)
00000
Shares Outstanding (Diluted)
00000
Shares Change
1007.68%1468.08%6291.41%22.71%88.02%
EPS (Basic)
-100000.00-1000000.00-20000000.00-1550000000.00-1360000000.00
EPS (Diluted)
-100000.00-1000000.00-20000000.00-1550000000.00-1360000000.00
EPS Growth
-----

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-5.59-12.27-6.85-7.11-6.33
Free Cash Flow Growth
-----
Free Cash Flow Per Share
-101948.00-2477390.00-21693900.00-1438750000.00-1571260000.00
Gross Margin
--100.00%100.00%100.00%
Operating Margin
---2103.41%-1277.83%-1210.73%
Profit Margin
---1858.01%-1095.28%-944.64%
FCF Margin
---1798.43%-1017.17%-1094.81%
EBITDA
-8.46-8.95-7.73-8.59-6.6
EBITDA Margin
---2029.13%-1228.76%-1141.00%
EBIT
-8.65-9.2-8.01-8.93-7
EBIT Margin
---2103.41%-1277.83%-1210.73%
Effective Tax Rate
1.62%4.18%5.42%9.80%10.58%
SEC Filings: 10-K · 10-Q